Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
Vistagen has reported positive outcomes from the exploratory Phase IIA trial of PH284 for the treatment of cancer cachexia.
Welcoming a newborn is something many couples dream of doing, but it can get complicated when conceiving becomes a roadblock.
With the holidays behind us, many Americans are seeing the numbers on the scale go up a pound or two. In fact, data shows that many American midlife ...
Intra-Cellular’s clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.